View in EDS PDF Full Text

Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.

Saved in:
Bibliographic Details
Title: Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
Authors: Raptis CE; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Berger CT; University Center for Immunology and Immunization Clinic, University Hospital Basel, Basel, Switzerland.; Translational Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland., Ciurea A; Department of Rheumatology, Zurich University Hospital, University of Zurich, Zurich, Switzerland., Andrey DO; Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Polysopoulos C; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Lescuyer P; Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland., Maletic T; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Riek M; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Scherer A; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., von Loga I; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Safford J; RheumaCura Foundation, Bern, Switzerland., Lauper K; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland., Möller B; Division of Rheumatology and Immunology, Inselspital, Bern University Hospital, Bern, Switzerland., Vuilleumier N; Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Finckh A; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland., Rubbert-Roth A; Division of Rheumatology and Immunology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.
Source: Frontiers in immunology [Front Immunol] 2022 Oct 13; Vol. 13, pp. 1016927. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36311791
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Raptis+CE%22">Raptis CE</searchLink>; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Berger+CT%22">Berger CT</searchLink>; University Center for Immunology and Immunization Clinic, University Hospital Basel, Basel, Switzerland.; Translational Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ciurea+A%22">Ciurea A</searchLink>; Department of Rheumatology, Zurich University Hospital, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Andrey+DO%22">Andrey DO</searchLink>; Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Polysopoulos+C%22">Polysopoulos C</searchLink>; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lescuyer+P%22">Lescuyer P</searchLink>; Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Maletic+T%22">Maletic T</searchLink>; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Riek+M%22">Riek M</searchLink>; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Scherer+A%22">Scherer A</searchLink>; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22von+Loga+I%22">von Loga I</searchLink>; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Safford+J%22">Safford J</searchLink>; RheumaCura Foundation, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lauper+K%22">Lauper K</searchLink>; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Möller+B%22">Möller B</searchLink>; Division of Rheumatology and Immunology, Inselspital, Bern University Hospital, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vuilleumier+N%22">Vuilleumier N</searchLink>; Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Finckh+A%22">Finckh A</searchLink>; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rubbert-Roth+A%22">Rubbert-Roth A</searchLink>; Division of Rheumatology and Immunology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Oct 13; Vol. 13, pp. 1016927. <i>Date of Electronic Publication: </i>2022 Oct 13 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36311791
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.1016927
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1016927
    Titles:
      – TitleFull: Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Raptis CE
      – PersonEntity:
          Name:
            NameFull: Berger CT
      – PersonEntity:
          Name:
            NameFull: Ciurea A
      – PersonEntity:
          Name:
            NameFull: Andrey DO
      – PersonEntity:
          Name:
            NameFull: Polysopoulos C
      – PersonEntity:
          Name:
            NameFull: Lescuyer P
      – PersonEntity:
          Name:
            NameFull: Maletic T
      – PersonEntity:
          Name:
            NameFull: Riek M
      – PersonEntity:
          Name:
            NameFull: Scherer A
      – PersonEntity:
          Name:
            NameFull: von Loga I
      – PersonEntity:
          Name:
            NameFull: Safford J
      – PersonEntity:
          Name:
            NameFull: Lauper K
      – PersonEntity:
          Name:
            NameFull: Möller B
      – PersonEntity:
          Name:
            NameFull: Vuilleumier N
      – PersonEntity:
          Name:
            NameFull: Finckh A
      – PersonEntity:
          Name:
            NameFull: Rubbert-Roth A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 10
              Text: 2022 Oct 13
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1